[{"NetIncomeLoss_1_Q2_USD":33703000.0,"Depreciation_2_Q2_USD":14400000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-17084000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-25752000.0,"InventoryFinishedGoods_0_Q2_USD":24259000.0,"InterestPaidNet_2_Q2_USD":5578000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":9934000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":210111000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q2_USD":35000.0,"LiabilitiesNoncurrent_0_Q2_USD":455848000.0,"PaidInKindInterest_2_Q2_USD":5022000.0,"EquityMethodInvestmentUnderlyingEquityInNetAssets_0_Q2_USD":2370000.0,"AccountsAndOtherReceivablesNetCurrent_0_Q2_USD":661000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":640578794.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":640578794.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":1100000000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":216457000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":200000.0,"LineOfCredit_0_Q2_USD":63537000.0,"OperatingLeaseLiability_0_Q2_USD":39057000.0,"PurchaseObligation_0_Q2_USD":154200000.0,"PaymentsToAcquireInvestments_2_Q2_USD":0.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":9934000.0,"FinanceLeaseInterestPaymentOnLiability_2_Q2_USD":86000.0,"GainLossOnDerivativeInstrumentsNetPretax_1_Q2_USD":-13000.0,"GainLossOnDerivativeInstrumentsNetPretax_2_Q2_USD":608000.0,"IncomeTaxesPaidNet_2_Q2_USD":-208000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":209000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":6506000.0,"TreasuryStockValue_0_Q2_USD":1791000.0,"InventoryValuationReserves_0_Q2_USD":3129000.0,"FinanceLeaseInterestExpense_2_Q2_USD":1200000.0,"AccountsReceivableGrossCurrent_0_Q2_USD":215925000.0,"LongTermLineOfCredit_0_Q2_USD":51489000.0,"TreasuryStockShares_0_Q2_shares":549907.0,"OtherInventorySupplies_0_Q2_USD":41298000.0,"ContractWithCustomerLiability_0_Q2_USD":17700000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":2960000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":77721000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":153852000.0,"OtherLiabilitiesAndDeferredRevenueNoncurrent_0_Q2_USD":24274000.0,"AssetsCurrent_0_Q2_USD":360054000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":5845000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-341000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1175000.0,"EquitySecuritiesFvNi_0_Q2_USD":24777000.0,"FinanceLeaseLiability_0_Q2_USD":5395000.0,"GainLossOnInvestments_2_Q2_USD":-323000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":7200000.0,"RepaymentsOfSeniorDebt_2_Q2_USD":0.0,"AccountsReceivableNetCurrent_0_Q2_USD":214352000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":18223000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":5890000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":47585000.0,"AssetsFairValueDisclosure_0_Q2_USD":25043000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":1026000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_2_Q2_USD":5907000.0,"InventoryWriteDown_2_Q2_USD":1700000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-240000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":327334000.0,"InventoryRawMaterials_0_Q2_USD":5826000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":48479000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":17608000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":39369000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":6604000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-4026000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":4009000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":6028000.0,"NumberOfReportableSegments_2_Q2_segment":2.0,"CommonStockValue_0_Q2_USD":6704000.0,"ProceedsFromIssuanceOrSaleOfEquity_2_Q2_USD":0.0,"Liabilities_0_Q2_USD":735391000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":28759000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":21612000.0,"OtherAssetsNoncurrent_0_Q2_USD":7487000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":14937000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":29874000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-16753000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":34086000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":2186000.0,"GainLossOnInvestments_1_Q2_USD":-189000.0,"IncreaseDecreaseInInventories_2_Q2_USD":21905000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":5604000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":251000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":1111000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":11277000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":22266000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":44318000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":393651000.0,"Supplies_0_Q2_USD":12999000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":382374000.0,"OtherAssetsCurrent_0_Q2_USD":19056000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":38138000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1404000.0,"Assets_0_Q2_USD":2323734000.0,"AccountsPayableCurrent_0_Q2_USD":44671000.0,"LiabilitiesCurrent_0_Q2_USD":279543000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":7479000.0,"PaymentsToAcquireProductiveAssets_2_Q2_USD":17149000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":2375000.0,"InventoryWorkInProcess_0_Q2_USD":4711000.0,"GainLossOnDispositionOfAssets1_2_Q2_USD":-156000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-57793000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":4435000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-3682000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1586000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":4037000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_2_Q2_USD":65000.0,"Goodwill_0_Q2_USD":671599000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.039,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-3682000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":4435000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":-323000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":-189000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":0.0,"NonoperatingIncomeExpense_2_Q2_USD":-4325000.0,"NonoperatingIncomeExpense_1_Q2_USD":12741000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":21612000.0,"NetIncomeLoss_2_Q2_USD":-25429000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":130540000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":7559000.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q2_USD":101312000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":118979000.0,"PrepaidInsurance_0_Q2_USD":6274000.0,"LinesOfCreditCurrent_0_Q2_USD":14463000.0,"OperatingLeasePayments_2_Q2_USD":9804000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":499125000.0,"AmortizationOfFinancingCosts_2_Q2_USD":411000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":1588343000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":249000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":61000.0,"EquitySecuritiesFvNiRealizedGainLoss_2_Q2_USD":5907000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.064,"DerivativeFairValueOfDerivativeAsset_0_Q2_USD":51000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":590000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":56884000.0,"LongTermDebtNoncurrent_0_Q2_USD":4201000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":51125000.0,"AdditionalPaidInCapital_0_Q2_USD":3147030000.0,"CommonStockSharesIssued_0_Q2_shares":670378701.0,"ContractWithCustomerLiabilityRevenueRecognized_11_Q2_USD":0.0,"ProceedsFromConvertibleDebt_2_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":2323734000.0,"OperatingLeaseCost_2_Q2_USD":9700000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":1028000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":16570000.0,"InventoryNet_0_Q2_USD":72965000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":39920000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-17906000.0,"OperatingIncomeLoss_1_Q2_USD":27179000.0,"OperatingIncomeLoss_2_Q2_USD":-13581000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":301207000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":512674000.0,"CommonStockSharesAuthorized_0_Q2_shares":1000000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2619000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":4671000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":9422000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"OperatingLeaseRightOfUseAsset_0_Q2_USD":38469000.0,"ShareBasedCompensation_2_Q2_USD":4037000.0,"GainLossOnSaleOfInvestments_2_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":4000000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":5395000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":10298000.0,"OperatingExpenses_2_Q2_USD":526255000.0,"RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1_Q2_USD":0.0,"RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_2_Q2_USD":94000.0,"AssetImpairmentCharges_2_Q2_USD":0.0,"AssetImpairmentCharges_1_Q2_USD":0.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":81539000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-63840000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1537848000.0,"VariableLeaseCost_2_Q2_USD":1600000.0,"LongTermInvestments_0_Q2_USD":26260000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":200000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":1573000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":1170000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":2435000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":91653000.0,"ProfitLoss_1_Q2_USD":33703000.0,"ProfitLoss_2_Q2_USD":-25429000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":0.05,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.04,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":0.0,"OperatingExpenses_1_Q2_USD":274028000.0,"EquityMethodInvestmentQuotedMarketValue_0_Q2_USD":7900000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-29111000.0,"Ticker":"OPK","CIK":"944809","name":"OPKO HEALTH, INC.","OfficialName":"OPKO Health Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2187471532.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20200731"}]